There are other fading stars in Novartis’ approved drugs portfolio too – the big-selling MS drug Gilenya and ophthalmology drug Lucentis could be threatened by generics or biosimilars in the coming years. Narasimhan has also struck several other deals of around this size, such as the $5.3 bil...
And so probably, many companies would say this is all manageable because it's relatively short term. When you start getting hundreds of drugs on this list, and you have drugs that are earlier in their life cycle in areas where you need more time to actually generate the peak sales and th...
as an adjuvant to or in combination to, other drugs e.g. immunosuppressive or immunomodulating agents or other anti-inflammatory agents, e.g. for the treatment or prevention of diseases mentioned above. For example, the Antibodies of the Invention may be used in combination with DMARD, e.g....
And so probably, many companies would say this is all manageable because it's relatively short term. When you start getting hundreds of drugs on this list, and you have drugs that are earlier in their life cycle in areas where you need more time to actually generate the peak sales an...
【novartis抗体公司】【novartis抗体公司】上海玉博生物ybiotech品牌工厂,提供定制抗体服务以及细胞株和菌株、胎牛血清、标准品和对照品、生化试剂、ELISA试剂盒、抗体和抗原、细胞因子、技术服务、实验耗材和消耗品、仪器设备等。 abcam抗体cst抗体sigma现货millipore抗体BECKMANMILTENYI RND EBIOSCIENCE ...